where the cfo is expected for her bail hearing morgan stanley chairman stephen roach is onset and byron wienns us at the top of the half hour if that weren't enough, another price target cut on apple, this time from morgan stanley, following ubs. "squawk alley" has the analysts behind that note first, markets are taking a blow dow down 180 bob pisani has more. >> this is what makes everybody nuts, discussions on trade talks. we move the markets with larry kudlow's discussion. look at what's happening you go into the markets. markets open you have positive momentum on the jobs report. the sentiment is with us here is larry, comes on with us here and says comments that larry kudlow was typically make. for example, progress, get a lot done in 90 days on trade talks he would consider extending that truce if good progress on tariff discussions. all positive we go up 15 points in the s&p, then drift around, then peter navarro on another network he says if progress is not made in 90 days, we will reinstate tariffs essentially. down, 15 this is what makes everybody crazy. it is hard to get a consist

. >> neil: byron wien, thank you. >> thank you. >> neil: he's called a lot of turns in markets.w recessions coming when nobody else did. saw a bull market coming when nobody else did. maybe we're close to that. that would define a turn-around and a comeback for stokes that sorely need it. a lot will hinge on what happens in washington and the crucial vote that is about 10 or 15 minutes away. don't guarantee that democrats would vote for it. but there's enough republicans still in power and still in control of this body the next few days that hope it will. after this. ♪ carla is living with metastatic breast cancer, which is breast cancer that has spread to other parts of her body. she's also taking prescription ibrance with an aromatase inhibitor, which is for postmenopausal women with hormone receptor-positive her2- metastatic breast cancer as the first hormonal based therapy. ibrance plus letrozole was significantly more effective at delaying disease progression versus letrozole. patients taking ibrance can develop low white blood cell counts, which may cause serious infection